Owner Protiva Biotherapeutics, Inc.

Inventors Lam, Kieu; Yaworski, Edward; Maclachlan, Ian

Agent Davies Collison Cave

Pub. Number AU-A-2009238175

PCT Pub. Number WO2009/127060

Priority 61/045,228 15.04.08 US

Filing date 15 April 2009

Wipo publication date 22 October 2009

C07K 14/775 (2006.01) Peptides having more than 20 amino acids

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/87 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

C12N 15/88 (2006.01) Mutation or genetic engineering